CLINICAL_TRIALS
trial_result
· 2024-01-17
Clinical Trial Update: Niemann-Pick Type C Treatment With Adrabetadex for Symptoms of Brain and Nervous System [Phase 3]
Summary
Phase 3 trial of Adrabetadex for Niemann-Pick Type C disease has been terminated; results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Mandos LLC | Conditions: Niemann-Pick Type C Disease | Phase 3 | Status: TERMINATED | Results posted: 2024-01-17